Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=064a2ea1-14db-4543-a154-7541eedb16b6 Date 1/11/2016 Company Name Tensha Therapeutics Mailing Address 55 Cambridge Parkway Cambridge, MA 02142 USA Company Description Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders. Website http://www.tenshatherapeutics.com Transaction Type M&A Transaction Amount $535,000,000 Transaction Round … Continue reading “Roche Acquires Tensha Therapeutics for $535,000,000”
Illumina Forms Grail in Quest for Ultimate Cancer Diagnostic
Illumina (NASDAQ: [[ticker:ILMN]]), the San Diego-based pioneer in gene-sequencing technology, says it has formed a new company called Grail to advance the sensitivity of technology already being used to detect infinitesimal pieces of DNA shed by cancerous tumors into the bloodstream. In a conference call with analysts Sunday evening, Illumina CEO Jay Flatley laid out … Continue reading “Illumina Forms Grail in Quest for Ultimate Cancer Diagnostic”
Accelerator, Gates Team Up in NY to Put $17M Into Rockefeller Startup
Seattle’s Accelerator Corp. made its long-awaited splash in New York last week with its first Manhattan biotech startup, Petra Pharma. Now here comes Lodo Therapeutics, Accelerator’s second startup, right in Petra’s wake. Lodo didn’t get the big $48 million round that Petra did last week. But the startup, built around the work of Rockefeller University … Continue reading “Accelerator, Gates Team Up in NY to Put $17M Into Rockefeller Startup”
Apple Buys Emotient, A Digital Analyst of Consumer Feelings
Apple has snapped up Emotient, a startup that scrutinizes human faces to gauge feelings and reactions, the Wall Street Journal and other media outlets are reporting. San Diego-based Emotient, founded in 2012, had been marketing its services to advertisers and researchers as a tool to predict how consumers would react to digital ads, movies, and … Continue reading “Apple Buys Emotient, A Digital Analyst of Consumer Feelings”
West Coast Bio Roundup: Big Waves, Big Cash & a Deep Pre-JPM16 Breath
I’d say this week was the calm before the J.P. Morgan storm, except that we on the West Coast have had plenty of storms this week. Perhaps not tornadoes, but weather big enough to churn up 50 foot waves yesterday. (Not to be confused with 50 Foot Wave.) Seeing those surf pictures from Mavericks, just … Continue reading “West Coast Bio Roundup: Big Waves, Big Cash & a Deep Pre-JPM16 Breath”
Phoenix, Baird’s New CEO, & Epic’s Growth: This Week’s WI Watchlist
Gyms are packed, forlorn Christmas trees lie on curbs, and the Green Bay Packers are in the NFL playoffs—it must be January in Wisconsin. Make it a resolution to stay plugged into the state’s innovation community, starting with these recent headlines: —Phoenix Nuclear Labs has raised $790,000 in debt financing, according to an SEC filing, … Continue reading “Phoenix, Baird’s New CEO, & Epic’s Growth: This Week’s WI Watchlist”
Seattle Roundup: CES News from Satellites to Connected Cars, & More
With CES sucking up all the early 2016 air, we’ve cherry picked a few announcements from the big technology show from Seattle-area companies including Planetary Resources, Kymeta, and UIEvolution. (Our correspondent João-Pierre S. Ruth is on the scene, covering all the droids you’re looking for and more.) We’re also tracking a merger between TalentWise and … Continue reading “Seattle Roundup: CES News from Satellites to Connected Cars, & More”
Car Wars: Mary Barra Talks GM’s Future, Nvidia Takes the Wheel at CES
Make way for autonomous cars on the highways ahead. That was a common theme from the auto industry at the CES technology trade show this week in Las Vegas. In years prior, carmakers tried almost too hard at CES to make their vehicles seem more hip by talking up connectivity and putting apps in cars … Continue reading “Car Wars: Mary Barra Talks GM’s Future, Nvidia Takes the Wheel at CES”
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More
Most everyone in biotech is on their way to San Francisco this weekend, making their annual trek to the J.P. Morgan Healthcare Conference for a few days of wall-to-wall meetings, schmoozing, and state-of-the-industry pontifications. But rather than get swallowed up by the conference maelstrom, biotechs try to get their big news out ahead of the … Continue reading “East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More”
Predictions for 2016: Self-Driving Cars, AI, and Brain Monitoring
Whether we have been in a tech bubble or not is frankly not that interesting. What is interesting is that the foundation for innovation is as strong as we’ve ever seen and entrepreneurs are bringing the future to reality at an amazing pace. Here are a few of my predictions for what we’ll see in … Continue reading “Predictions for 2016: Self-Driving Cars, AI, and Brain Monitoring”
Ringing in the Years (and Ears): What I’d Like to Hear in 2016
For the last 30 years, the tech revolution in PCs, Macs, and Smartphones has been largely connected with our eyes, not our ears. 2016 will mark the beginning of the commercialization of virtual and augmented reality, and although our visual experience will continue to be the main focus for these radical changes, it’s time our … Continue reading “Ringing in the Years (and Ears): What I’d Like to Hear in 2016”
Myomo Garners $620,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=41592a0a-b0cd-4ba2-9b2c-65a1314a8550 Date 1/8/2016 Company Name Myomo Mailing Address One Broadway 14th Floor Cambridge, MA 02142 USA Company Description Myomo is pioneering NeuroRobotics, a new category of non-invasive medical device technology to help people relearn how to move severely weak or partially paralyzed limbs. Originally an acronym for Muscle-Motion, Myomo (pronounced MY-O-MO) was … Continue reading “Myomo Garners $620,000 New Round”
C4 Therapeutics Lands $73,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f631cfa5-5f7f-4ac4-8de0-a02fbc6d0a91 Date 1/8/2016 Company Name C4 Therapeutics Mailing Address Undisclosed Cambridge, MA 10018 USA Company Description C4 Therapeutics is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases. Website http://www.c4thera.com Transaction Type Venture Equity Transaction Amount $73,000,000 Transaction Round Series A Proceeds … Continue reading “C4 Therapeutics Lands $73,000,000 Series A Round”
Bottlenose Receives $2,196,557 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f83086a3-aabd-4169-b983-401c988891d7 Date 1/8/2016 Company Name Bottlenose Mailing Address 15301 Venture Blvd. Bldg D Sherman Oaks, CA 91403 USA Company Description Bottlenose is a real-time discovery engine for the social web. It measures what the crowd is paying attention to, so you can discover and focus on what’s important now. Bottlenose is used … Continue reading “Bottlenose Receives $2,196,557 New Financing Round”
Bruin Biometrics Lands $9,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7bbc9a6a-a438-4890-b944-a1e082282ca6 Date 1/8/2016 Company Name Bruin Biometrics Mailing Address 10960 Wilshire Blvd. Los Angeles, CA 90024 USA Company Description At BBI, we are relentlessly committed to using technology to improve the way that health care is delivered. By developing innovative medical device systems that can cost-effectively detect and monitor select medical conditions … Continue reading “Bruin Biometrics Lands $9,000,000 Series A Funding Round”
Sviral Obtains $200,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f2c7bf6-99a2-40a6-a22c-2a76fc3ba605 Date 1/8/2016 Company Name Sviral Mailing Address 1196 Borregas Ave. Sunnyvale, CA 94089 USA Company Description SVIRAL has created an enabling technology, which radically changes the very definition of computing. It solves THE problem in Computer Science – namely the inability of programmers to effectively utilize the combined processing power of … Continue reading “Sviral Obtains $200,000 New Financing Round”
Platzi Receives $2,100,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24ad0495-28ae-42b0-aecd-414b681f3641 Date 1/8/2016 Company Name Platzi Mailing Address Undisclosed Mountain View, CA 94102 USA Company Description Platzi cracked online education. It teaches courses on design, marketing and programming with a 70% completion rate, to over 80,000 students worldwide. All of their classes are livestreamed and recorded, with real-time collaboration among students and … Continue reading “Platzi Receives $2,100,000 Seed Round”
Inpher Garners $950,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4ea80355-f3f1-4c86-a323-446e3ad1901f Date 1/8/2016 Company Name Inpher Mailing Address 245 5th Street San Francisco, CA 94103 USA Company Description Inpher, Inc. operates a platform and framework to build applications for end-to-end encryption and cloud based unstructured data search. It offers users to search and retrieve ranked results on their data without the cloud … Continue reading “Inpher Garners $950,000 New Funding”
Pierry Software Secures New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=976d56be-74c7-4c26-9816-b375d7343047 Date 1/8/2016 Company Name Pierry Software Mailing Address 785 Broadway Street Redwood City, CA 94063 USA Company Description Founded in 2008, Pierry Software was built with one goal in mind—helping organizations large and small make the most out of their online presence. This goal continues to drive us forward and over … Continue reading “Pierry Software Secures New Funding Round”
Authorea Receives $1,031,198 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b9dc927b-fbf0-47b9-a5a5-68ca18182986 Date 1/8/2016 Company Name Authorea Mailing Address 43 West 23rd Street 2nd Floor New York, NY 10010 USA Company Description Authorea is a tool for writing and managing scholarly documents. It has been referred to as a hybrid between Google Docs and Github, for research. Authorea makes it easy to write … Continue reading “Authorea Receives $1,031,198 New Round”
Allergan Acquires Anterios for $90,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f697eca7-4384-42a5-a4f6-c02ca5bce39b Date 1/8/2016 Company Name Anterios Mailing Address 142 West 57th St. New York, NY 10019 USA Company Description Anterios Inc. uses nanotechnology to provide a delivery system to administer drugs and cosmetics. Anterios Inc. was formerly known as Encapsion Inc. The company was incorporated in 2006 and is based in New … Continue reading “Allergan Acquires Anterios for $90,000,000”
InSightec Secures $22,000,000 Series D Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b4e5349c-382a-4932-8c44-0c65cbfee1ef Date 1/8/2016 Company Name InSightec Mailing Address 4851 LBJ Freeway Dallas, TX 75244 USA Company Description InSightec developed ExAblate 2000– a product that integrates Magnetic Resonance Imaging (MRI) with focused ultrasound energy — as a new treatment modality that can replace invasive procedures and provide therapeutic alternatives to millions of patients … Continue reading “InSightec Secures $22,000,000 Series D Round”
Exosome Diagnostics Closes $60M Series B for Liquid Biopsy Test
It may have taken a couple of years, but Exosome Diagnostics has finally raised the money it said it wanted to potentially launch its liquid biopsy-based diagnostic test. Exosome announced today it has closed a $60 million Series B round of funding, money that it is putting toward getting its first oncology products on the … Continue reading “Exosome Diagnostics Closes $60M Series B for Liquid Biopsy Test”
Syfy Labs Brings “The Expanse” to MakerBot 3D Printers at CES
Syfy really wants tech lovers and hobbyists to get onboard with one of its latest TV programs—and the timing might even help 3D-printer company MakerBot Industries. Viewers of science-fiction series The Expanse can now 3D-print replica spaceships from the show through a collaboration between the Syfy cable network and Brooklyn-based MakerBot. Introduced on Wednesday at CES … Continue reading “Syfy Labs Brings “The Expanse” to MakerBot 3D Printers at CES”
Former Cubist CEO Mike Bonney Joins Third Rock Ventures
As CEO of Cubist Pharmaceuticals, Mike Bonney spent a decade building a mid-cap biotech company that eventually accepted a massive buyout. Now he’ll be helping start new companies from scratch. Bonney (pictured) has joined Boston-based Third Rock Ventures, which specializes in launching startups in cutting-edge areas of biomedicine. Third Rock also tends to start companies, … Continue reading “Former Cubist CEO Mike Bonney Joins Third Rock Ventures”
Massachusetts Aims to Raise Its Stature in Digital Health
Massachusetts is home to a sizable healthcare technology sector—some 250 companies, according to state estimates, including names like American Well, Athenahealth, Kyruus, PillPack, and Maxwell Health. But a group of prominent stakeholders from the public and private sectors wants to take the state’s digital health cluster to new heights. An initiative announced Thursday aims to … Continue reading “Massachusetts Aims to Raise Its Stature in Digital Health”
$100M Richer, Cempra Still Needs FDA OK To Market Pneumonia Drug
Cempra is raising nearly $100 million through a stock sale to bring its first drug, a new antibiotic called solithromycin, to market as a pneumonia treatment. But Chapel Hill, NC-based Cempra (NASDAQ: [[ticker:CEMP]]) can’t move forward with those plans until the FDA gives its blessing. That could take a while. The firm said in a … Continue reading “$100M Richer, Cempra Still Needs FDA OK To Market Pneumonia Drug”
Roundup: Inforum, Techstars Mobility, LevelEleven, Occipital
Here’s a look at innovation news from around Michigan: —Inforum, a professional women’s organization, is now accepting applications for an upcoming master class aimed at second-stage entrepreneurs. Led by Patti Glaza and Paula Sorrell, the class provides a confidential forum where emerging startup founders will meet monthly to evaluate their company’s operations and identify new … Continue reading “Roundup: Inforum, Techstars Mobility, LevelEleven, Occipital”
Xconomy Forum: Robo Madness: The A.I. Explosion
Major advances are happening in robotics and the driving force behind it—artificial intelligence. Now companies of all sizes are using emerging A.I. technologies from deep learning to computer vision to natural language processing to build their businesses—and impact our daily lives. Think Google, Facebook, iRobot, and a whole new generation of startups: the technologies are … Continue reading “Xconomy Forum: Robo Madness: The A.I. Explosion”
UW Lab Links Healthcare Innovators with Primary Care Doctors
There is no shortage of innovation in healthcare, but startups and even large companies face challenges in getting their new technologies in the hands of the front-line doctors who would implement them. Enter the University of Washington’s new Primary Care Innovations Lab, which aims to connect private companies with doctors and other experts to assist … Continue reading “UW Lab Links Healthcare Innovators with Primary Care Doctors”
Flash Sale: Web Retailer Gilt Groupe Sells to Hudson Bay for $250M
Discount fashion and merchandise retailer Gilt Groupe has sold itself in a fitting fashion: to Hudson Bay Co. for $250 million, a price tag that is a steep discount to the hefty billion-dollar valuation it once held. Hudson Bay, the operator of department store brands such as Saks Fifth Avenue, is trying to build on … Continue reading “Flash Sale: Web Retailer Gilt Groupe Sells to Hudson Bay for $250M”
Former Abbott, Melinta Exec Steps into Head Seat at Aegerion
Mary Szela has been named the CEO of Cambridge, MA-based Aegerion Pharmaceuticals (NASDAQ: [[ticker:AEGR]]). Szela replaces Sandford Smith, who has been Aegerion’s interim CEO since Marc Beer resigned in July. She’s coming off a stint as CEO of Melinta Therapeutics, and spent more than a decade at Abbott Laboratories before that. Smith, meanwhile, will serve … Continue reading “Former Abbott, Melinta Exec Steps into Head Seat at Aegerion”
Minnesota Data Center Sold For $46M As Epic, Mayo Strike Another Deal
Epic Systems, the healthtech giant based in Verona, WI, is expanding its already sizeable footprint in neighboring Minnesota. At least nine health systems headquartered in the state use or plan to use Epic’s electronic health records (EHR) software to schedule appointments, document patient information, bill for services, and perform other tasks. One of them is … Continue reading “Minnesota Data Center Sold For $46M As Epic, Mayo Strike Another Deal”
UniQure’s Shares Rise on Early Gene Therapy Data For Hemophilia
There are a slew of gene therapy companies trying to develop a long-lasting, perhaps even permanent treatment for hemophilia. The proof that these companies can really make an impact on the disease will come out in dribs and drabs from clinical trials over the next several years, and today, one of them, Dutch firm UniQure, … Continue reading “UniQure’s Shares Rise on Early Gene Therapy Data For Hemophilia”
With $100M, Guardant Health to Expand Reach of Blood Test for Cancer
We’ve all heard that dust is at least partly made up of dead skin cells. However true or untrue that may be, living tissue that is growing rapidly, such as a cancerous solid tumor, does indeed shed dead cells. When a person has a tumor that is growing, it sheds dead cells and their contents—including … Continue reading “With $100M, Guardant Health to Expand Reach of Blood Test for Cancer”
Yahoo Draws Fire From Activist Investor, Plans Workforce Cuts
As hopeful tech innovators strut their stuff at the annual CES show in Las Vegas this week, Yahoo’s continuing troubles illustrate what can happen to a former tech star that doesn’t stay ahead of the curve. The talk surrounding Sunnyvale, CA-based Yahoo (NASDAQ: [[ticker:YHOO]]) no longer focuses on how CEO Marissa Mayer can revive the … Continue reading “Yahoo Draws Fire From Activist Investor, Plans Workforce Cuts”
The Myth Of A Secure Back Door For Encryption
It seems like an appealing move–give the FBI and other law enforcement agencies, as well as our spy organizations, a back door—a “golden key”—to unlock encrypted communications to help catch criminals and terrorists and to protect Americans from harm. This notion of heightened protection is particularly compelling in the wake of the recent terrorist attacks … Continue reading “The Myth Of A Secure Back Door For Encryption”
A Tipping Point in Robotics, and My Five Predictions for 2016
While scientists are making progress in understanding how the mind works, robotics has failed to live up to the expectations set in the 1950s and ‘60s for human-like robots, exemplified by the Jetson’s cartoon character, Rosie the robot maid. Since the rejuvenation of robotics began in the 1980s, we have discovered that engineering and building … Continue reading “A Tipping Point in Robotics, and My Five Predictions for 2016”
Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup
When physician-scientist Jay Bradner left the Dana-Farber Cancer Institute last year, he left behind some key scientific work that had already intrigued a group of investors. Bradner is now president of the Novartis Institutes for Biomedical Research, but his Dana-Farber research continued in the hands of others. It’s now the basis of a new startup … Continue reading “Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup”
NextCure Receives $67,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=abc4af3b-1726-4fdd-a785-7a99d25ebe92 Date 1/7/2016 Company Name NextCure Mailing Address Undisclosed New Haven, CT 06501 USA Company Description NextCure, launched in 2015, is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class … Continue reading “NextCure Receives $67,000,000 Series A Financing”
Zagster Secures $1,499,926 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62e7bae9-2d12-4295-8826-cc5a1c851e6a Date 1/7/2016 Company Name Zagster Mailing Address 24 Thorndike Street Cambridge, MA 02141 USA Company Description We’re passionate cyclists who love fresh air, good exercise and emission-free transportation. We believe we’re creating the future of transportation through our easy to use bike sharing systems. We want to use our years of … Continue reading “Zagster Secures $1,499,926 New Round”
Exosome Diagnostics Garners $60,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3830b1ce-8276-444a-8c7e-d31d9c6ff7c7 Date 1/7/2016 Company Name Exosome Diagnostics Mailing Address 840 Memorial Drive Cambridge, MA 02139 USA Company Description Exosome Diagnostics, Inc. is focused on commercializing minimally invasive molecular diagnostics using body fluids. Website http://www.exosomedx.com Transaction Type Venture Equity Transaction Amount $60,000,000 Transaction Round Series B Proceeds Purposes Exosome Diagnostics expects to use … Continue reading “Exosome Diagnostics Garners $60,000,000 Series B Financing Round”
UIEvolution Secures $5,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=378ea7ef-e0cf-4dcc-b62f-6d3e6aeb426d Date 1/7/2016 Company Name UIEvolution Mailing Address 11332 NE 122nd Way Kirkland, WA 98034 USA Company Description At UIEvolution we see a future where our software technology and solutions power dynamic application experiences for any device, platform or network enabling consumers to access their content anytime, anywhere. Website http://www.uievolution.com Transaction Type … Continue reading “UIEvolution Secures $5,000,000 New Funding”
Apple Acquires Emotient for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d583b2f2-a44d-4b21-817f-d44f5ea0e36c Date 1/7/2016 Company Name Emotient Mailing Address 4435 Eastgate Mall San Diego, CA 92121 USA Company Description Emotient is the leading authority on facial expression recognition and analysis technologies that are enabling a future of emotion aware computing. Website http://www.emotient.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A … Continue reading “Apple Acquires Emotient for Undisclosed Sum”
Scalr Obtains $7,349,989 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b9adedce-65b1-4318-881f-99fcc687f631 Date 1/7/2016 Company Name Scalr Mailing Address 461 Bush Street 4th Floor San Francisco, CA 94108 USA Company Description Established in 2007 at the very start of the cloud computing revolution, Scalr is a growing, mature, and profitable business, in this for the long haul. We started our careers as operations … Continue reading “Scalr Obtains $7,349,989 New Financing”
Alector Obtains $29,500,000 Series D Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e3f447be-fb93-478f-adde-a8b028c82a71 Date 1/7/2016 Company Name Alector Mailing Address 953 Indiana Street San Francisco, CA 94107 USA Company Description Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunolgy and human genetics to develop novel therapeutics for Alzheimer’s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Website http://www.alector.com Transaction Type … Continue reading “Alector Obtains $29,500,000 Series D Financing”
Guardant Health Lands $100,000,000 Series D Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=014db92e-45f6-423f-9d9f-cc53650f67f0 Date 1/7/2016 Company Name Guardant Health Mailing Address 505 Penobscot Dr. Redwood City, CA 94063 USA Company Description Guardant360 is the only biopsy-free tumor sequencing test that tracks tumor genomics in real-time and identifies associated treatment options. Website http://www.guardanthealth.com Transaction Type Venture Equity Transaction Amount $100,000,000 Transaction Round Series D Proceeds … Continue reading “Guardant Health Lands $100,000,000 Series D Funding Round”
Square Panda Receives New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=27c4f6ef-51f0-4b61-9b60-e65d0b54139d Date 1/7/2016 Company Name Square Panda Mailing Address 935 Benecia Avenue Sunnyvale, CA 94085 USA Company Description It is often said that a child’s most precious gift is their curiosity. At Square Panda we are creating a new generation of products that let children follow their curiosity through play activities involving … Continue reading “Square Panda Receives New Financing Round”
SiSense Receives $50,000,000 Series D Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3fac7123-3666-46a8-9868-678591db8012 Date 1/7/2016 Company Name SiSense Mailing Address 14 Wall Street New York, NY 10005 USA Company Description We are an innovative business intelligence (BI) software company that is leading the way into a new era of business intelligence, reporting, dashboarding and business analytics. Website http://www.sisense.com Transaction Type Venture Equity Transaction Amount … Continue reading “SiSense Receives $50,000,000 Series D Financing Round”
Petra Pharma Receives $48,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=326836f8-36cc-491f-a7b5-e4653c19db63 Date 1/7/2016 Company Name Petra Pharma Mailing Address 450 E. 29th St. New York, NY 10016 USA Company Description Petra Pharma’s approach interrogates the novel enzyme targets responsible for a variety of important cellular processes, including cell division, growth, trafficking and signaling to develop therapies to improve patient health. Website Undisclosed … Continue reading “Petra Pharma Receives $48,000,000 Series A Financing Round”